Objective-A highly polygenic etiology and high degree of allele-sharing between ancestries have been well-elucidated in genetic studies of rheumatoid arthritis. Recently, the high-density genotyping array Immunochip for immune disease loci identified 14 new rheumatoid arthritis risk loci among individuals of European ancestry. Here, we aimed to identify new rheumatoid arthritis risk loci using Korean-specific Immunochip data. Kim et al. Methods-We analyzed Korean rheumatoid arthritis case-control samples using the Immunochip and GWAS array to search for new risk alleles of rheumatoid arthritis with anti-citrullinated peptide antibodies. To increase power, we performed a meta-analysis of Korean data with previously published European Immunochip and GWAS data, for a total sample size of 9,299 Korean and 45,790 European case-control samples.
Introduction
Rheumatoid arthritis (RA; OMIM180300) is a chronic and systemic autoimmune disease affecting up to 1% of the adult population worldwide. 1 Total heritability of RA was estimated to be ~65% from a previous twin study that compared the disease discordance in monozygotic twins with dizygotic twins. 2 To date, >50 risk loci have been discovered among individuals of European and Asian ancestry, 3, 4 but only ~16% of the heritability (or ~25% of the genetic heritability) could be explained by the confirmed risk loci. 5 Current RA genetic studies have revealed a highly polygenic etiology by an inferred genetic architecture that hundreds (if not thousands) of common SNPs with modest effect and smaller number of rare causal variants account for total genetic heritability of RA. 6 A previous study reported the majority of the RA susceptibility alleles are shared among individuals of European and Japanese ancestry (correlation coefficient for effect sizes between ancestries=0.82). 3 This observation suggests that there are shared causal variants between the two populations, and further suggests that a large cohort study using multiple ancestries can be powerful to detect new RA risk loci. 7 individuals of European ancestry (n=2,840), for a total sample size of 9,299 Korean and 45,790 European case-control samples (online supplementary table S1).
METHODS

Korean Subjects, Genotyping, Imputation and Quality Control
A total of 4,689 subjects including 1,525 RA cases [average age=52.7 (17-82); female=83.4%] with anti-citrullinated peptide antibodies (ACPA) and 3,164 healthy controls [average age=39.4 (16-79); female=60.7%] were genotyped by the customized iChip array at multiple centers (SNP Genetics, Inc. Korea After merging the GWAS datasets, we applied the quality control criteria of MAF≥0.01, p value of HWE<10 −4 and call rate>95% in controls and cases. The quality control-passed control-case GWAS data were pre-phased to construct haplotypes of the autosomal chromosomes by SHAPEIT 9 and subsequent imputation was performed by IMPUTE2 10 using the 1000 Genomes Project phase I reference panel. The imputed data was filtered by the criteria of MAF>1%, Maximum probability≥0.9, p value of HWE<10 −4 and Call rate per SNP≥0.95. A total of 65,014 iChip markers were extracted from the imputed data (online supplementary table S3).
Principal component analysis was performed by the SNP & Variation Suite 7 software using the SNPs with MAF>5% and linkage disequilibrium (LD) r 2 <0.2 with other SNPs in a +/ −250kb window. Cryptic relatedness with high kinship coefficient (>0.177) corresponding to the duplicate or 1st-degree relative was estimated by the KING software. 11 Quantilequantile (Q-Q) plots were generated using the SNPs associated with reading and writing ability to estimate inflation.
In order to examine the third-effect SNP rs2027498 in TNFSF4, an independent Korean cohort including 1,254 RA cases [average age=53.1 (17-88); female=87.2%; ACPA(+)=71.1%, ACPA(−)=2.0%, ACPA(not tested)=26.9%] and 1,011 healthy controls [average age=54.0 (40-86); female=80.0%] was recruited. The genotyping was performed using Sequenom iPlex platform at LabGenomics Co. LTD, showing a genotype call rate of 98.1% and no deviation from HWE.
All patients fulfilled the 1987 criteria of the American College of Rheumatology. The level of ACPA in the Korean RA patients was measured by using the ImmuLisa CCP2 enzymelinked immunosorbent assay kit. Anti-cyclic citrullinated peptide (Anti-CCP) >25 units/ml was considered as positive for ACPA.
European Subjects, Imputation and quality control
The seven European iChip data (ES, NL, SE-E, SE-U, UK, US and i2b2/CORRONA) listed in supplementary table S1 were reported in two previous studies. 4, 12 ACPA-negative samples were additionally removed from all data passing the quality control criteria in the previous studies. The ACPA-positive iChip data were further filtered for missingness per SNP/Individual (<0.01), MAF (<0.01) and HWE (p<10 −7 ). Each European GWAS data (BRASS, CANADA, NARAC2 and WTCCC) independent of the Immunochip data was pre-phased and imputed by MaCH 13 and Minimac 14 using the high-density phased reference data from the 1000 Genome Project instead of the reference phase of the HapMap2 data used in the previous study. 4 The imputed data was filtered to restrict the analysis to ACPA positive cases and SNPs with MAF≥1% and imputationr 2 ≥0.5. Q-Q plots were generated for each European collection using the SNPs associated with reading and writing ability. All patients in the reported datasets fulfilled the 1987 criteria of the American College of Rheumatology or were diagnosed by a professional rheumatologist.
RA Association Test
odds ratio (OR) and 95% confidence interval (CI) were calculated by PLINK 15 with adjustment for top 5 or 10 PCs in the logistic regression to test whether each autosomal SNP was associated with susceptibility to RA. A fixed-effects inverse-variance meta-analysis of the association results from each collection and a heterogeneity test of the SNP effects among the collections were conducted by the GWAMA software. 16 Statistical power to detect RA association was calculated using the CaTS Power calculator.
Secondary-Effect Analysis
The presence of independent effect within the new RA loci with dense iChip markers was examined by conditioning on a lead SNP and/or other independent-effect SNPs and PCs as covariates. The conditional analysis using forward stepwise logistic regression for each collection and subsequent meta-analysis was performed by PLINK 15 and GWAMA 16 , respectively. When a SNP was significant with p<5×10 −5 in the conditional analysis, the SNP was considered to have independent effect.
The genotypes of the independent-effect SNPs (rs61828284, rs4090392 and rs2027498) in 1q25/TNFSF4 were phased using PLINK 15 . The haplotypes were examined in the European collections that were successfully genotyped or imputed for all three SNPs. In Koreans, rs61828284 and rs4090392 were too rare to infer the haplotype or to perform statistical analysis.
Proxy SNP Analysis
The HaploReg v2 software 17 was used to search the proxy SNPs of the RA-associated SNPs and to annotate the functional effects at the SNP position. Association of each SNP in the novel RA loci with the expression of the genes within the locus was evaluated using published eQTL data from the lymphoblastoid cell lines of the 856 healthy female twins of the MuTHER resource 18 and the HapMap population 19 in the Genevar v3.2.0 web-based software 20 .
RESULTS
Korean-only Analysis
We first analyzed the Korean iChip + GWAS data from 2,234 cases and 7,065 controls. A total of 96,952 iChip SNPs passed quality control in the Korean iChip dataset (online supplementary table S2) and the GWAS-based imputed dataset (online supplementary table S3 and figure S1). Principal components analysis was used to correct for population stratification, showing no outliers (online supplementary figure S2 ). We performed logistic regression analyses to calculate OR and 95% CI adjusted for the top 10 principal components in the iChip and GWAS datasets independently, followed by an inversevariance-weighted fixed-model meta-analysis. Q-Q plots of p values and inflation factors indicated little evidence of systematic bias (λ 1000 = 1.010; online supplementary figure S3).
While we were able to replicate four known RA risk loci (HLA, PADI4, STAT4 and RASGRP1), no new RA risk loci were identified in the Korean-only analysis at a genomewide level of significance (p<5×10 −8 ; online supplementary figure S4). However, this analysis was underpowered to achieve the genome-wide significance for alleles with modest effect (online supplementary figure S5 ).
Korean-European meta-analysis: Identification of 8 new RA risk loci
Since most known rheumatoid arthritis risk alleles are shared among individuals of European and Asian ancestry, 3 we performed a meta-analysis with recently published iChip + GWAS data 4 and new iChip data 12 derived from case-control samples of European ancestry. The GWAS data were imputed to iChip markers using 1000 Genome Project data. A total of 133,816 SNPs were analyzed in the Korean-European meta-analysis (λ 1000 = 1.003) (online supplementary figure S1 and S3).
In a combined analysis, we found 8 new RA susceptibility loci passing a genome-wide significance threshold of p<5×10 −8 (figure 1). For 7 of the 8 loci, the new signal of association was driven by adding the Korean data to the previously published European iChip + GWAS data. One locus on 1q25 (containing the TNFSF4 gene), was identified by adding new European iChip data to the previously published iChip + GWAS European dataset (table 1) . A Cochran's Q test with a forest plot for each associated locus indicated no obvious evidence of heterogeneity across sample collections (figure 2 and online supplementary table S4).
The lead SNP at the UBASH3A locus, rs1893592, demonstrated evidence of genetic heterogeneity among the collections, (p q-test =0.0029). However, this heterogeneity was derived mainly from single collection of European ancestry (NL), rather than heterogeneity between Asian and European populations ( figure 2) .
In addition to the novel loci, we confirmed association at 35 known non-HLA loci at p<5×10 −8 (figure 1). Another 12 known RA risk loci included on the iChip array demonstrated consistent direction of effects at a suggestive level of significance (5×10 −8 <p≤1.31×10 −3 ) (online supplementary table S4). The only previously reported RA risk allele in a Japanese population that did not demonstrate an association in our analysis (p>0.05) was at the CD244 locus (online supplementary table S4).
The SNP with the strongest signal of association at each of the new and known loci (excluding the CD244 locus) exhibited a high correlation of effect sizes between populations, with the same allele conferring RA risk in individuals of Korean and European ancestry for most loci (correlation coefficient=0.91; online supplementary figure S6 ). There were, however, 10 SNPs in which the European risk allele was present at a very low MAF among individuals of Korean ancestry, as has been observed for the risk allele of PTPN22. 21
Three independent risk alleles in 1q25/TNFSF4
For the 8 novel loci, we investigated for evidence of independent risk alleles by performing conditional analysis on the lead SNP in the combined Korean-European sample set. We found evidence for two additional risk alleles at the 1q25/TNFSF4 locus: both rs4090392 (p cond =3.82×10 −7 ) and rs2027498 (p cond =1.16×10 −5 ) contributed signals independent of the lead SNP rs61828284 (online supplementary figure S7, S8 and table S5). However, 2 of the 3 1q25/TNFSF4 SNPs were very rare among Koreans (rs61828284 and rs4090392); the third SNP (rs2027498) was common in Koreans and showed the same direction of effect in both populations (OR EUR =0.90 [0.86-0.94] and OR KOR =0.95 [0.84-1.09]). Among Europeans, these three SNPs are in weak LD (r 2 ≤0.1, |D'|≤0.66). The TAA haplotype carrying the three protective alleles exhibited the greatest protection against RA (OR=0.67 [0.57-0.77]; online supplementary figure S9).
It was possible that third effect SNP was associated in Koreans as well as Europeans because the effect size of the SNP was similar between populations. In order to increase power (52%), we attempted additional genotyping of rs2027498 for an independent set of 1,254 RA cases and 1,011 controls from Korea, but did not find evidence of association (p meta =0.87; OR=1.01; online supplementary Table S6 ).
Identification of potentially causal SNPs by trans-ethnic mapping
To find the most likely causal variants in the 7 new loci with consistent signals of association in both Koreans and Europeans (excluding 1q25/TNFSF4), we examined local patterns of LD and annotated putative functional variants. The lead SNPs at these 7 loci were in LD with 55 and 51 SNPs at r 2 ≥0.9 in the 1000 Genome Project data of East Asian (CHB+JPT) and European (CEU) ancestry, respectively. Considering the overlap between the two populations, we observed only 37 SNPs in LD with the lead SNPs in both populations, none of which was a nonsynonymous, nonsense or splicing-site variant (online supplementary table S7).
When we applied the trans-ethnic mapping to 21 known RA loci and 7 new RA loci showing association in meta-analysis (p<5×10 −8 ) and each of populations (p<0.05), we could narrow down the number of proxy SNPs from 492 SNPs (445 SNPs in Koreans and 231 SNPs in European) to 182 SNPs in the 21 known loci. Among the 28 RA loci, 16 and 19 loci had the decreased number of the proxy SNPs in Koreans and Europeans, respectively (online supplementary figure S10 and table S8 ).
An example of the trans-ethnic mapping approach is shown in figure 3 . Only 2 out of 8 SNPs were in LD with the lead SNP in both populations: rs909685 (lead SNP) and rs2069235 (r 2 =0.92 in Asian and r 2 =1.00 in European). This locus contains SYNGR1 (an integral membrane protein associated with presynaptic vesicles in neuronal cells, which is also known as a susceptibility locus for primary biliary cirrhosis. 22 Both variants lie within putative functional sequences (e.g., transcriptional factor-binding motif alteration, histone marks, DNase hypersensitivity, DNA-binding proteins). Furthermore, both SNPs were identical to the most significant eQTL associated with SYNGR1 expression from lymphoblastoid cell lines in previous four studies (online supplementary figure  S11 ). 18, 19, 23, 24 
DISCUSSION
Based on previous Asian-European studies 3, 25 and theoretical estimates of the polygenic architecture of RA 6 , a large number of common genetic variants with modest effect size on risk of RA are expected to be discovered by a trans-ethnic approach. Here, we identified 8 new loci with relatively modest OR (0.81≤OR≤0.91 and 1.10≤OR≤1.13) using a large cohort of Korean and European populations, bring the number of RA loci to >60.
There are several important observations from our study. First, the association of the new loci exhibits a similar trend of ORs between Korean and European populations. Further, there were similar trends of ORs among the 13 data collections and no remarkable deviation between observed and reported MAF, which indicates little possibility of systemic bias or error.
Second, our study continues to emphasize the importance of T cell biology in the pathogenesis of RA. 26 Four of the 8 new loci contain genes with established function in CD4+ T cells. TNFSF4, which encodes a cytokine OX40L in the TNF ligand family, is involved in the regulation of T cell-mediated immune responses. 27 EOMES encodes a transcription factor with a crucial role in differentiation of CD8+ T cells and homeostasis of effector and memory T-cells. 28 ETS1 encodes a transcription factor that regulates the differentiation of Th1 cells, regulatory T cells and B cells by affecting the function of other key regulators like T-bet, Foxp3 and Blimp-1. 29 UBASH3A encodes a T-cell ubiquitin ligand that acts as a negative regulator of T-cell receptor (TCR)-mediated signaling. 30 Third, many of new RA risk loci are also associated with other complex diseases, especially autoimmune diseases (TNFSF4 with systemic lupus erythematosus (SLE) 31, 32 and Crohn's disease 33 ; EOMES with multiple sclerosis 34 ; ETS1 with SLE 31, 32, 35 and celiac disease 36 ; RAD51B with primary biliary cirrhosis 37 and breast cancer 38 ; UBASH3A with type 1 diabetes 39, 40 and vitiligo 41 ; SYNGR1 with primary biliary cirrhosis 22 ). LBH and UBASH3A have been suggested as shared risk loci of RA and celiac diseases in a meta-analysis of RA and celiac datasets, 42 but not established in each disease alone. Although functional connection between the new loci and RA pathogenesis is not elucidated yet, the overlap suggests a shared etiology across autoimmune diseases. 43 All associated genes are known to be highly expressed in immune cells like T cells or broadly expressed across tissues including blood cells (online supplementary table S9).
Fourth, we found evidence that multiple alleles contribute to risk at one of newly discovered loci. Using a conditional test among individuals of European ancestry, we found that the lead SNP rs61828284 in 1q25/TNFSF4 could not account for the secondary effect at rs4090392, nor at the third-effect SNP, rs2027498. Notably, the association of the secondary-effect SNP but not the third effect SNP became strengthened by conditioning of the lead SNPs in the meta-analysis. A similar trend was observed among all the Europeanancestry collections. The masked or strengthened significance of the secondary SNP before or after conditioning may be the result of Simpson's paradox, which has been shown in a celiac locus, SOCS1. 44 Finally, we used a trans-ethnic approach to narrow the list of putative causal alleles at each of the 28 RA risk loci with association signals in both Asians and Europeans. We narrowed down 563 proxy SNPs (in LD with the lead SNP at r 2 >0.90 in one or the other population) to 219 putative causal variants (in LD with the lead SNP in both populations). One example is shown at the SYNGR1 locus ( figure 3) . Similarly, the lead SNP at UBASH3A (rs1893592) among the new loci shared only one proxy SNP in both populations, which is located in 3-bp downstream of the boundary between exon 10 and intron 10 of UBASH3A. The minor allele C of rs1893592 disrupts the consensus sequence R (=A or G) of the splice donor site in contrast to the major allele A, although biological validation is required for the potential alternative splicing.
A limitation of our study is the coverage of the iChip among individuals of Asian ancestry. The customized iChip array was largely designed to capture variants identified in the CEU cohort of the 1000 Genomes Project pilot study. As a result, we observe that a large portion (42%) of the iChip markers were not polymorphic or rare (MAF<0.01) in the Korean dataset, compare to 22% in the European iChip dataset. Nevertheless, the SNPs with MAF≥0.01 in the Korean population in the iChip target regions were still dense and almost overlapped with the SNP with MAF ≥ 0.01 in the European population (online supplementary figure S2 ) so that we could perform a high-quality meta-analysis, identify new RA risk loci, and narrow the list of putative causal variants through a trans-ethnic approach.
In summary, we identified 8 new RA loci using a dense genetic mapping approach, providing additional insight into the pathogenesis of RA risk. Fine-mapping and trans-ancestral comparison narrowed the list of putative causal variants that may explain the underlying signal of association at these 8 new loci. Overlap of proxy SNPs shared in the ancestries and regulatory SNPs in the SYNGR1 locus. (A) Regional association plot for the meta-analysis for the RPL3-SYNGR1 locus in the chromosome 22. The best hit was found at rs909685 in the intron of SYNGR1. The 13-kb region containing all proxy SNPs of rs909685 was highlighted with pink. Coordinates are based on the hg19 assembly. (B) The proxy SNPs (circle) correlated with the lead SNP rs909685 in Korean and/or European (r 2 ≥ 0.9). The two proxy SNPs, rs909685 (red) and rs2069235 (orange), were observed in both population in contrast to the others (grey). (C)
The functional annotation of the proxy SNPs. Each proxy SNP was annotated for that it significantly alters the transcription factor binding motifs by the alleles and that it is in histone-mark region, DNase-hypersensitive site (DHS), Protein-binding site and eQTL. Table 1 Association results for SNPs in novel RA loci 
